La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

JBM (Healthcare) Salute del bilancio

Salute finanziaria criteri di controllo 6/6

JBM (Healthcare) ha un patrimonio netto totale di HK$1.0B e un debito totale di HK$115.0M, che porta il suo rapporto debito/patrimonio netto a 11.3%. Le sue attività totali e le sue passività totali sono rispettivamente HK$1.4B e HK$366.8M. L'EBIT di JBM (Healthcare) è HK$162.2M rendendo il suo rapporto di copertura degli interessi 21. Ha liquidità e investimenti a breve termine pari a HK$167.2M.

Informazioni chiave

11.3%

Rapporto debito/patrimonio netto

HK$115.00m

Debito

Indice di copertura degli interessi	21x
Contanti	HK$167.21m
Patrimonio netto	HK$1.02b
Totale passività	HK$366.75m
Totale attività	HK$1.39b

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Aug 03

Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

Jul 28

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( HK$367.5M ) di 2161 superano le sue passività a breve termine ( HK$221.6M ).

Passività a lungo termine: Le attività a breve termine di 2161 ( HK$367.5M ) superano le sue passività a lungo termine ( HK$145.2M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 2161 ha più liquidità del suo debito totale.

Riduzione del debito: Il rapporto debito/patrimonio netto di 2161 si è ridotto da 557.7% a 11.3% negli ultimi 5 anni.

Copertura del debito: Il debito di 2161 è ben coperto dal flusso di cassa operativo ( 166.3% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di 2161 sono ben coperti dall'EBIT ( 21 x copertura).

JBM (Healthcare) Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Recent updates

New minor risk - Market cap size

Upcoming dividend of HK$0.041 per share

JBM (Healthcare) Limited Approves Final Dividend for the Year Ended March 31, 2024

JBM (Healthcare) Limited, Annual General Meeting, Aug 06, 2024

Full year 2024 earnings released: EPS: HK$0.15 (vs HK$0.064 in FY 2023)

Jbm (Healthcare) Limited Proposes Final Dividend for the Year Ended March 31, 2024, Payable on September 17, 2024

Investor sentiment improves as stock rises 17%

JBM (Healthcare) Limited Announces Board Changes, Effective 9 March 2024

New minor risk - Market cap size

JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Upcoming dividend of HK$0.035 per share at 2.8% yield

JBM (Healthcare) Limited Announces Change of Company Secretary

JBM (Healthcare) Limited Announces Change of Company Secretary

First half 2024 earnings released: EPS: HK$0.069 (vs HK$0.024 in 1H 2023)

JBM (Healthcare) Limited Announces Interim Dividend for the Six Months Ended 30 September 2023, Payable on 28 December 2023

JBM (Healthcare) Limited to Report First Half, 2024 Results on Nov 22, 2023

Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 19%

Upcoming dividend of HK$0.025 per share at 2.8% yield

JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon

New minor risk - Dividend sustainability

New minor risk - Share price stability

Investor sentiment improves as stock rises 21%

New minor risk - Earnings quality

JBM (Healthcare) Limited, Annual General Meeting, Aug 01, 2023

Full year 2023 earnings released: EPS: HK$0.064 (vs HK$0.028 in FY 2022)

JBM (Healthcare) Limited to Report Fiscal Year 2023 Results on Jun 15, 2023

Investor sentiment improves as stock rises 15%

Investor sentiment deteriorates as stock falls 20%

Non-Executive Chairman of the Board recently bought HK$650k worth of stock

Investor sentiment improves as stock rises 22%

Investor sentiment improved over the past week

JBM (Healthcare) Limited Declares Interim Dividend for the Six Months Ended 30 September 2022, Payable on 29 December 2022

First half 2023 earnings released: EPS: HK$0.024 (vs HK$0.011 in 1H 2022)

Less than half of directors are independent

JBM (Healthcare) Limited to Report Q2, 2023 Results on Nov 25, 2022

JBM (Healthcare) Limited, Annual General Meeting, Sep 23, 2022

Full year 2022 earnings released

JBM (Healthcare) Limited to Report Fiscal Year 2022 Results on Jun 29, 2022

Less than half of directors are independent

Board Member recently sold HK$121k worth of stock

First half 2022 earnings released

Investor sentiment improved over the past week

Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

Full year 2021 earnings released: EPS HK$0.028 (vs HK$0.057 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

JBM (Healthcare) Limited has completed an IPO in the amount of HKD 53.6232 million.

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane